Verition Fund Management
KURA icon

Verition Fund Management’s Kura Oncology KURA Stock Holding History

Verition Fund Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30,766
Closed -$178K – 3897
2025
Q2 		$178K Sell
30,766
-63,665
-67% -$390K ﹤0.01% 3392
2025
Q1 		$623K Sell
94,431
-21,163
-18% -$165K ﹤0.01% 2431
2024
Q4 		$1.01M Buy
115,594
+27,199
+31% +$391K ﹤0.01% 2050
2024
Q3 		$1.73M Sell
88,395
-101,614
-53% -$2.06M 0.01% 1513
2024
Q2 		$3.91M Sell
190,009
-171,811
-47% -$3.53M 0.02% 865
2024
Q1 		$7.72M Sell
361,820
-103,773
-22% -$2.02M 0.05% 440
2023
Q4 		$6.7M Buy
+465,593
New +$4.58M 0.05% 355
2022
Q4 		– Sell
-576,240
Closed -$7.87M – 2459
2022
Q3 		$7.87M Buy
576,240
+38,153
+7% +$588K 0.09% 265
2022
Q2 		$9.86M Buy
538,087
+44,949
+9% +$647K 0.2% 97
2022
Q1 		$7.93M Buy
+493,138
New +$7.12M 0.1% 214
2021
Q4 		– Sell
-77,749
Closed -$1.46M – 2686
2021
Q3 		$1.46M Sell
77,749
-202,337
-72% -$3.81M 0.01% 779
2021
Q2 		$5.84M Buy
280,086
+85,001
+44% +$2.11M 0.05% 214
2021
Q1 		$5.51M Buy
195,085
+51,788
+36% +$1.64M 0.06% 177
2020
Q4 		$4.68M Buy
143,297
+85,776
+149% +$3.01M 0.04% 213
2020
Q3 		$1.76M Buy
+57,521
New +$1.27M 0.04% 277

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Verition Fund Management's KURA Position: Q3 2025 in Review

Verition Fund Management sold out of Kura Oncology (KURA) in Q3 2025, closing a stake of 30,766 shares — an estimated $178K sold.

Verition Fund Management first reported a position in KURA in Q3 2020 and held it in 15 quarters. The position peaked at $9.86M in Q2 2022. 200 funds tracked by Wall St. Rank hold KURA as of Q3 2025.

  • Verition Fund Management reported no remaining Kura Oncology position as of Q3 2025 after selling out during the quarter.
  • Verition Fund Management sold 30,766 Kura Oncology shares in Q3 2025, an estimated $178K.
  • Verition Fund Management first reported a position in Kura Oncology in Q3 2020 and held it in 15 quarters.
  • Verition Fund Management's Kura Oncology position peaked at $9.86M in Q2 2022.
  • 200 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.